메뉴 건너뛰기




Volumn 9, Issue 3, 2014, Pages 580-589

Naphthyridines as novel bet family bromodomain inhibitors

Author keywords

BET family bromodomains inhibitors; epigenetic readers; inflammation; naphthyridines

Indexed keywords

1 BENZYL 7 (3,5 DIMETHYLISOXAZOL 4 YL) 8 METHOXY 1H IMIDAZO [4,5 C][1,5]NAPHTHYRIDINE 2(3H) ONE; 2 (3,5 DIMETHYLISOXAZOL 4 YL)PYRIDIN 4 AMINE; 4 (BENZYLAMINO) 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXAMIDE; 4 (BENZYLAMINO) 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 4 [(2 ( TERT BUTYL)PHENYL)AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 4 [(2 (TERT BUTYL)PHENYL)AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 4 [(CYCLOHEXYLMETHYL)AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 4 [[2 ( TERT BUTYL)PHENYL]AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 1,6 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 4 [[2 (TERT BUTYL)PHENYL]AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXAMIDE; 5 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXYPYRIDIN 3 AMINE; 6 (3,5 DIMETHYLISOXAZOL 4 YL)PYRIDIN 2 AMINE; 7 (3,5 DIMETHYLISOXAZOL 4 YL) 4 [(2 FLUOROPHENYL)AMINO] 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXAMIDE; 7 (3,5 DIMETHYLISOXAZOL 4 YL) 4 [(2 FLUOROPHENYL)AMINO] 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 4 [[2 (TRIFLUOROMETHOXY) PHENY]AMINO] 1,5 NAPHTHYRIDINE 3 CARBOXAMIDE; 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 4 [[2 (TRIFLUOROMETHOXY) PHENYL]AMINO] 1,5 NAPHTHYRIDINE 3 CARBOXYLIC ACID; 7 (3,5 DIMETHYLISOXAZOL 4 YL) 8 METHOXY 1 [2 (TRIFLUOROMETHOXY)PHENYL] 1H IMIDAZOL[4,5 C][1,5]NAPHTHYRIDINE 2(3H) ONE; ANTIINFLAMMATORY AGENT; BROMODOMAIN AND EXTRA TERMINAL PROTEIN; ETHYL 4 (BENZYLAMINO) 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 4 [(CYCLOHEXYLMETHYL)AMINO] 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 4 [[2 ( TERT BUTYL)PHENYL]AMINO] 7 (3,5 DIMETHYLISOXAZOL 4YL) 1,6 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 4 [[2 (TERT BUTYL)PHENYL]AMINO] 7 (3,5 DIMETHYLISOXAZOL 4YL) 1,8 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 4 [[2 (TERT BUTYL)PHENYL]AMINO] 7 (3,5 DIMETHYLISOXAZOL 4YL) 6 METHOXY 1,5 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 7 (3,5 DIMETHYLISOXAZOL 4 YL) 4 OXO 1,4 DIHYDRO 1,6 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 7 (3,5 DIMETHYLISOXAZOL 4 YL) 4 OXO 1,4 DIHYDRO 1,8 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 4 [[2 (TRIFLUOROMETHOXY)PHENYL]AMINO] 1,5 NAPHTHYRIDINE 3 CARBOXYLATE; ETHYL 7 (3,5 DIMETHYLISOXAZOL 4 YL) 6 METHOXY 4 OXO 1,4 DIHYDRO 1,5 NAPHTHYRIDINE 3 CARBOXYLATE; NAPHTHYRIDINE DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84896692123     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201300259     Document Type: Article
Times cited : (33)

References (17)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.